{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:30:00Z","timestamp":1772011800005,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Lipodystrophy syndromes are characterized by a progressive metabolic impairment secondary to adipose tissue dysfunction and may have a genetic background. Congenital generalized lipodystrophy type 4 (CGL4) is an extremely rare subtype, caused by mutations in the polymerase I and transcript release factor (<jats:italic>PTRF<\/jats:italic>) gene. It encodes for a cytoplasmatic protein called caveolae-associated protein 1 (Cavin-1), which, together with caveolin 1, is responsible for the biogenesis of caveolae, being a master regulator of adipose tissue expandability. Cavin-1 is expressed in several tissues, including muscles, thus resulting, when dysfunctional, in a clinical phenotype characterized by the absence of adipose tissue and muscular dystrophy. We herein describe the clinical phenotypes of two siblings in their early childhood, with a phenotype characterized by a generalized reduction of subcutaneous fat, muscular hypertrophy, distinct facial features, myopathy, and atlantoaxial instability. One of the siblings developed paroxysmal supraventricular tachycardia leading to cardiac arrest at 3 months of age. Height and BMI were normal. Blood tests showed elevated CK, a mild increase in liver enzymes and triglycerides levels, and undetectable leptin and adiponectin concentrations. Fasting glucose and HbA1c were normal, while Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was mildly elevated. Both patients were hyperphagic and had cravings for foods rich in fats and sugars. Genetic testing revealed a novel pathogenic mutation of the <jats:italic>CAVIN1<\/jats:italic>\/<jats:italic>PTRF<\/jats:italic> gene (NM_012232 exon1:c T21A:p.Y7X) at the homozygous state. The diagnosis of lipodystrophy can be challenging, often requiring a multidisciplinary approach, given the pleiotropic effect, involving several tissues. The coexistence of generalized lack of fat, myopathy with elevated CK levels, arrhythmias, gastrointestinal dysmotility, and skeletal abnormalities should prompt the suspicion for the diagnosis of CGL4, although phenotypic variability may occur.<\/jats:p>","DOI":"10.3389\/fendo.2023.1212729","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:02:05Z","timestamp":1689206525000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["A new mutation in the CAVIN1\/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature"],"prefix":"10.3389","volume":"14","author":[{"given":"Valentina","family":"Mancioppi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Daffara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Romanisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Ceccarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Pelosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferruccio","family":"Santini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Bellone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Mellone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Baricich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Rabbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Aimaretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baris","family":"Akinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Prodam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/S40618-018-0887-Z","article-title":"Diagnosis and treatment of lipodystrophy: a step-by-step approach","volume":"42","author":"Ara\u00fajo-Vilar","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.873699","article-title":"Adipokines, hepatokines and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation","volume":"13","author":"Ren","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/S42255-019-0095-Y","article-title":"Leptin and the endocrine control of energy balance","volume":"1","author":"Friedman","year":"2019","journal-title":"Nat Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2018.00640","article-title":"Obesity, fat mass and immune system: role for leptin","volume":"9","author":"Francisco","year":"2018","journal-title":"Front Physiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2020.00039\/BIBTEX","article-title":"Congenital generalized lipoatrophy (Berardinelli-seip syndrome) type 1: description of novel AGPAT2 homozygous variants showing the highly heterogeneous presentation of the disease","volume":"11","author":"Ceccarini","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-1243","article-title":"Caveolar dysfunction and lipodystrophies","volume":"186","author":"Patni","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4274\/JCRPE.GALENOS.2019.2019.0124","article-title":"Current diagnosis, treatment and clinical challenges in the management of lipodystrophy syndromes in children and young people","volume":"12","author":"\u00d6zen","year":"2020","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104073","DOI":"10.1016\/J.LPM.2021.104073","article-title":"Autoimmunity in lipodystrophy syndromes","volume":"50","author":"Ceccarini","year":"2021","journal-title":"Presse Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1152\/PHYSREV.00032.2020","article-title":"Lipodistrophy: a paradigm for understanding the consequences of \u201coverloading\u201d adipose tissue","volume":"101","author":"Lim","year":"2021","journal-title":"Physiol Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/S11892-018-1099-9","article-title":"Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/17446651.2020.1735360","article-title":"Diagnostic strategies and clinical management of lipodystrophy","volume":"15","author":"Foss-Freitas","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/DBI21-0006","article-title":"When adipose tissue lets you down: understanding the functions of genes disrupted in lipodystrophy","volume":"71","author":"Rochford","year":"2022","journal-title":"Diabetes"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2011-1159","article-title":"Clinical review#: lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges","volume":"10","author":"Chiquette","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5772\/INTECHOPEN.88667","article-title":"Lipodystrophy - a rare condition with serious metabolic abnormalities","author":"Hoa Chung","year":"2020","journal-title":"Rare Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/JHG.2013.107","article-title":"Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies","volume":"59","author":"Nolis","year":"2014","journal-title":"J Hum Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PGEN.1000874","article-title":"Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations","volume":"6","author":"Rajab","year":"2010","journal-title":"PloS Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40842-020-00095-3","article-title":"Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X CAVIN1 gene variant","volume":"6","author":"Sorkina","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29245\/2572-9411\/2018\/2.1147","article-title":"Congenital generalized lipodystrophy","volume":"3","author":"Gomes Lima","year":"2018","journal-title":"J Rare Dis Res Treat"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/JBC.M707890200","article-title":"A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization","volume":"283","author":"Liu","year":"2008","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1042\/BST20190380","article-title":"Lessons from cavin-1 deficiency","volume":"48","author":"Liu","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1096\/FJ.14-251165","article-title":"Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability","volume":"28","author":"Perez-Diaz","year":"2014","journal-title":"FASEB J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2021.803189","article-title":"Molecular and cellular bases of lipodystrophy syndromes","volume":"12","author":"Zammouri","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/NRENDO.2015.123","article-title":"Congenital generalized lipodystrophies\u2013new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5152\/DIR.2017.17019","article-title":"Determining residual adipose tissue characteristics with MRI in patients with various subtypes of lipodystrophy","volume":"23","author":"Altay","year":"2017","journal-title":"Diagn Interv Radiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/AJMG.A.33578","article-title":"Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations","author":"Shastry","year":"2010","journal-title":"Am J Med Genet A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.05.015","article-title":"Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: a multicenter study","volume":"27","author":"Akinci","year":"2017","journal-title":"Neuromuscular Disord"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01331","article-title":"Postmortem findings in a young man with congenital generalized lipodystrophy, type 4 due to CAVIN1 mutations","volume":"104","author":"Patni","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2003-032140","article-title":"Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy","volume":"89","author":"Javor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0B013E32832D4A33","article-title":"Inherited lipodystrophies and hypertriglyceridemia","volume":"20","author":"Simha","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2021.585887","article-title":"Leptin and obesity: role and clinical implication","volume":"12","author":"Obradovic","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B34","unstructured":"AkinciB\n            SahinozM\n            OralE\n          EndotextLipodystrophy syndromes: presentation and treatment2018"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/IJO.2014.131","article-title":"Percentile reference values for anthropometric body composition indices in European children from the IDEFICS study","author":"Nagy","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMG.2015.02.002","article-title":"Novel nonsense mutation in the PTRF gene underlies congenital generalized lipodystrophy in a consanguineous Saudi family","volume":"58","author":"Jelani","year":"2015","journal-title":"Eur J Med Genet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/AJMG.A.32457","article-title":"Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability","author":"Simha","year":"2008","journal-title":"Am J Med Genet A"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMG.2016.05.001","article-title":"Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4","volume":"59","author":"Akinci","year":"2016","journal-title":"Eur J Med Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2010.06.016","article-title":"A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4","volume":"101","author":"Dwianingsih","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/J.NMD.2013.02.005","article-title":"Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood","volume":"23","author":"Murakami","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-14-89","article-title":"Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy","volume":"14","author":"Ardissone","year":"2013","journal-title":"BMC Med Genet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/S00431-015-2556-Y","article-title":"Berardinelli-seip syndrome and achalasia: a shared pathomechanism","volume":"174","author":"van der Pol","year":"2015","journal-title":"Eur J Pediatr"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2016-1086","article-title":"Maladaptative autophagy impairs adipose function in congenital generalized lipodystrophy due to cavin-1 deficiency","volume":"101","author":"Salle-Teyssi\u00e8res","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1297\/CPE.28.1","article-title":"Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report","volume":"28","author":"Takeyari","year":"2019","journal-title":"Clin Pediatr Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2019.103819","article-title":"Congenital generalized lipodystrophy: the evaluation of clinical follow-up findings in a series of five patients with type 1 and two patients with type 4","volume":"63","author":"G\u00fcne\u015f","year":"2020","journal-title":"Eur J Med Genet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2022-0022","article-title":"Congenital generalized lipodystrophy type 4 due to a novel PTRF\/CAVIN1 pathogenic variant in a child: effects of metreleptin substitution","volume":"35","author":"Adiyaman","year":"2022","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2016-3628","article-title":"Effects of metreleptin in pediatric patients with lipodystrophy","volume":"102","author":"Brown","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.869042\/FULL","article-title":"Case report: precision COVID-19 immunization strategy to overcome individual fragility: a case of generalized lipodystrophy type 4","volume":"13","author":"Zaffina","year":"2022","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"869042","DOI":"10.1371\/JOURNAL.PONE.0087173","article-title":"Divergent metabolic phenotype between two sisters with congenital generalized lipodystrophy due to double AGPAT2 homozygous mutations. a clinical, genetic and in silico study","volume":"9","author":"Cort\u00e9s","year":"2014","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/ER.2017-00226","article-title":"Effects of leptin on the skeleton","volume":"39","author":"Reid","year":"2018","journal-title":"Endocr Rev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2010-1030","article-title":"The central regulation of bone mass, the first link between bone remodeling and energy metabolism","volume":"95","author":"Karsenty","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2003.10.019","article-title":"Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy","volume":"53","author":"Moran","year":"2004","journal-title":"Metabolism"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2014-1353","article-title":"Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy","volume":"53","author":"Christensen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2018.11.004","article-title":"Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease","volume":"51","author":"Hussain","year":"2019","journal-title":"Pathology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1212729\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:02:08Z","timestamp":1689206528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1212729\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":54,"alternative-id":["10.3389\/fendo.2023.1212729"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1212729","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"article-number":"1212729"}}